DUSYNC
Live / Registered — Registered (as of 20 Jan 2026)
What this means for you
Registered since 20 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99315417
- Registration number
- 8111099
- Mark type
- Stylized text
- Filed
- 01 Aug 2025
- Published for opposition
- 02 Dec 2025
- Registered
- 20 Jan 2026
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 20 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION WRITTEN
- 24 Oct 2025 — ASSIGNED TO EXAMINER
- 01 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 01 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED